1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Alzheimer's Disease Research Program - Standard Awards" is currently closed and not accepting applications.
Alzheimer's Disease Research Program - Standard Awards is sponsored by BrightFocus Foundation. The Alzheimer's Disease Research Program provides funding for US domestic and international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer's disease.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Alzheimer's Disease Research Request for Proposals | BrightFocus Foundation Alzheimer’s Disease Research Request for Proposals Alzheimer’s Disease Research, a BrightFocus Foundation program, provides research funds for U.S. domestic and international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer’s disease.
We are committed to supporting scientists from diverse backgrounds to foster creativity and innovation in addressing complex scientific challenges and strongly encourage applications from individuals who are from groups underrepresented in Alzheimer’s disease research. Explore Recently Funded Research Request for Proposals Opens All deadlines are 5:00 p. m.
EST (Washington, D. C.) on the day of the deadline.
Please note that a Letter of Intent is no longer required for this program. Applicants must submit a full proposal by the stated deadline. Application guidelines, instructions, and eligibility criteria will be available when applications open.
Alzheimer’s Disease Research offers two types of awards: Postdoctoral Fellowship Awards Must be within 5 years of degree conferral. Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards fund projects in an established laboratory that will serve as the basis for the applicant’s independent research career.
Award Amount: $100,000 per year (total value $200,000) Within 5 years of degree conferral Guidelines & Instructions The standard award program is divided into two tracks, each designed to support high risk, high reward, innovative research in Alzheimer’s disease and related dementias (ADRD).
Award Amount: $100,000 per year (total value $300,000) Early Career Investigator Track: Within 15 years of degree conferral Independent Investigator Track: Applicants from outside the Alzheimer’s field and cross-disciplinary approaches are strongly encouraged. Applicants should not hold an active R01 (or equivalent) for the same of closely related research topic. This program is highly competitive and prioritizes innovation.
Guidelines & Instructions Browse related Alzheimer’s disease research news and information. Breaking News Dispatch: Diversifying the Alzheimer’s Disease Treatment Portfolio Read the latest research news and findings from the latest international Alzheimer’s conference. Can Better Sleep Slow Alzheimer’s?
New BrightFocus-funded research suggests restoring sleep may help protect the brain from dementia progression, and a common insomnia drug could help lead the way. Breaking News Dispatch: Alzheimer’s Oral Therapies, Prevention Strategies, and Targeted Treatments Emerge Get the latest research news from the 2026 International Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) conference.
Can Targeting the Immune System Slow the Progression of Alzheimer’s? BrightFocus Alzheimer’s Disease Research grant recipient Joshua Emmerson, PhD, is exploring a certain type of immune cell’s unexpected role in Alzheimer’s disease—and what it could mean for protecting the brain.
Unlocking the Brain’s Regenerative Potential to Fight Alzheimer’s María Llorens-Martín is investigating why the brain stops making new cells in Alzheimer’s—and how fixing that process could change lives. Breaking News Dispatch: New Findings on GLP-1 Drugs and Alzheimer’s, Novel Treatments in Development, and More Get the latest news from the 2025 Clinical Trials on Alzheimer’s Disease (CTAD) conference.
4 Takeaways from Alzheimer’s Fast Track 2025 This innovative meeting hosted by BrightFocus Foundation bridges cutting-edge science, mentorship, and community building for early-career researchers. Understanding Alzheimer’s & Exploring New Frontiers in Treatment Watch a conversation inspired by the documentary film Taking Care and the latest research in Alzheimer’s therapies.
New Clues in the Fight Against Alzheimer’s: Q&A with Dr. Keith Hengen During World Alzheimer’s Month, Alzheimer’s Disease Research grantee Dr. Keith Hengen joined BrightFocus’ Dr. Sharyn Rossi on Instagram Live to talk brain health—how the brain functions, why quality sleep matters, and tips to keep your brain healthy.
Breaking News Dispatch: Diversifying the Alzheimer’s Disease Treatment Portfolio Read the latest research news and findings from the latest international Alzheimer’s conference. Can Better Sleep Slow Alzheimer’s? New BrightFocus-funded research suggests restoring sleep may help protect the brain from dementia progression, and a common insomnia drug could help lead the way.
Breaking News Dispatch: Alzheimer’s Oral Therapies, Prevention Strategies, and Targeted Treatments Emerge Get the latest research news from the 2026 International Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) conference. Can Targeting the Immune System Slow the Progression of Alzheimer’s?
BrightFocus Alzheimer’s Disease Research grant recipient Joshua Emmerson, PhD, is exploring a certain type of immune cell’s unexpected role in Alzheimer’s disease—and what it could mean for protecting the brain. Unlocking the Brain’s Regenerative Potential to Fight Alzheimer’s María Llorens-Martín is investigating why the brain stops making new cells in Alzheimer’s—and how fixing that process could change lives.
Breaking News Dispatch: New Findings on GLP-1 Drugs and Alzheimer’s, Novel Treatments in Development, and More Get the latest news from the 2025 Clinical Trials on Alzheimer’s Disease (CTAD) conference. 4 Takeaways from Alzheimer’s Fast Track 2025 This innovative meeting hosted by BrightFocus Foundation bridges cutting-edge science, mentorship, and community building for early-career researchers.
Understanding Alzheimer’s & Exploring New Frontiers in Treatment Watch a conversation inspired by the documentary film Taking Care and the latest research in Alzheimer’s therapies.
New Clues in the Fight Against Alzheimer’s: Q&A with Dr. Keith Hengen During World Alzheimer’s Month, Alzheimer’s Disease Research grantee Dr. Keith Hengen joined BrightFocus’ Dr. Sharyn Rossi on Instagram Live to talk brain health—how the brain functions, why quality sleep matters, and tips to keep your brain healthy.
According to the current listing, eligibility includes: Independent researchers who can submit proposals through their institutions, oversee their own projects, and supervise employees. PIs may have only one currently funded BrightFocus project. Confirm the full requirements in the official notice before applying.
The current listing shows $300,000 over three years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 1, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Alzheimer's Disease Research Program - Standard Awards is funded by BrightFocus Foundation. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.